SCHEMBL24470933

SCHEMBL24470933

Cc1oc2ccc(O)cc2c1C(=O)NC1(C(N)=O)CCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.47
▸ HTT P42858 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ POLB P06746 2/20 0.47
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAOB P27338 3/20 0.39
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ EYA3 Q99504 2/20 0.38
▸ SLC22A12 Q96S37 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24470861 0.81 CASP3 (0.62) GAAHTTLMNAMEN1KMT2A
SCHEMBL29713074 0.81 CASP3 (0.62) GAAHTTLMNAMEN1KMT2A
SCHEMBL24470862 0.79 GAA (0.45) GAALMNAPOLBSMN1; SMN2MEN1
SCHEMBL24485160 0.79 SLC26A4 (0.48) GAAHTTLMNAPOLBSMN1; SMN2
SCHEMBL29629791 0.79 SLC26A4 (0.48) GAAHTTLMNAPOLBSMN1; SMN2
SCHEMBL24485156 0.78 GAA (0.45) GAAHTTLMNAPOLBSMN1; SMN2
SCHEMBL29629918 0.78 GAA (0.45) GAAHTTLMNAPOLBSMN1; SMN2
SCHEMBL24470742 0.78 SLC26A4 (0.52) GAAHTTLMNAPOLBSMN1; SMN2
SCHEMBL24485157 0.78 CASP3 (0.46) GAAHTTLMNAPOLBSMN1; SMN2
SCHEMBL29629889 0.78 CASP3 (0.46) GAAHTTLMNAPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4259613-A1 ARYL DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2023-10-18 — — EP disclosed
CN-116761796-A Aryl derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2023-09-15 — — CN disclosed
WO-2022112345-A1 ARYL DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2022-06-02 — — WO disclosed
WO-2022112345-A1 ARYL DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2022-06-02 — — WO disclosed
Send feedback